KCT0000085已完成未知
Efficacy of lamivudine plus adefovir therapy or adefovir add on therapy for entecavir-resistant hepatitis B patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 37
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational Study
入排标准
- 年龄范围
- 15(Year) 至 80(Year)（—）
- 性别
- All
入选标准
- •ETV-refractory chronic hepatitis B patients
排除标准
- •co-infections (hepatitis C virus or human immunodeficiency virus) or other concomitant liver disease such as alcoholic liver disease or autoimmune liver disease.
研究者
相似试验
已完成
2 期
Lamivudine and Adefovir to Treat Chronic Hepatitis BHBV (Hepatitis B Virus)HepatitisHepatitis BNCT00023309National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)41
Unknown
3 期
Lamivudine Plus Adefovir Versus Telbivudine Plus Adefovir in Lamivudine Resistant Chronic Hepatitis BChronic Hepatitis BNCT01270165Yonsei University110
已完成
不适用
A comparison of lamivudine plus adefovir and entecavir for chronic hepatitis B patients whose HBV DNA levels are below the level of detection by PCRJPRN-UMIN000000898niversity of Tokyo Department of Gastroenterology, Faculty of Medicine200
已完成
不适用
A comparison of lamivudine plus adefovir and entecavir for chronic hepatitis B patients who had not previously received a nucleoside analogue: A randomized trialChronic hepatitis BJPRN-UMIN000000884niversity of Tokyo Department of Gastroenterology, Faculty of Medicine200
Unknown
4 期
Compare Continuing Lamivudine Plus Adefovir or Adefovir Versus Switching to Entecavir Plus Adefovir in Patients With LAM-resistant Chronic Hepatitis BHepatitis B, ChronicNCT02482272Asan Medical Center90